IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 87 filers reported holding IRADIMED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,618 | -9.9% | 12,590 | -3.1% | 0.00% | – |
| Q2 2023 | $620,143 | +18.5% | 12,990 | -2.3% | 0.00% | – |
| Q1 2023 | $523,355 | +39.1% | 13,300 | 0.0% | 0.00% | – |
| Q4 2022 | $376,257 | -1.5% | 13,300 | +4.7% | 0.00% | – |
| Q3 2022 | $382,000 | -11.4% | 12,700 | 0.0% | 0.00% | – |
| Q2 2022 | $431,000 | -21.9% | 12,700 | +3.3% | 0.00% | – |
| Q1 2022 | $552,000 | -2.8% | 12,300 | 0.0% | 0.00% | – |
| Q4 2021 | $568,000 | +37.5% | 12,300 | 0.0% | 0.00% | – |
| Q3 2021 | $413,000 | +14.1% | 12,300 | 0.0% | 0.00% | – |
| Q2 2021 | $362,000 | +16.0% | 12,300 | +1.7% | 0.00% | – |
| Q1 2021 | $312,000 | +13.0% | 12,100 | 0.0% | 0.00% | – |
| Q4 2020 | $276,000 | +6.6% | 12,100 | 0.0% | 0.00% | – |
| Q3 2020 | $259,000 | -17.3% | 12,100 | -10.4% | 0.00% | – |
| Q2 2020 | $313,000 | +48.3% | 13,500 | +36.4% | 0.00% | – |
| Q1 2020 | $211,000 | – | 9,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
| Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
| RK Capital | 213,200 | $9,560,000 | 1.88% |
| Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
| G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
| EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
| Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
| EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
| Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |